Clinical Trial Update: IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial update for IN10018 in metastatic melanoma, evaluating both monotherapy and combination therapy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• IN10018

Snippet

Sponsor: InxMed (Shanghai) Co., Ltd. | Conditions: Metastatic Melanoma | Phase 1 | Status: COMPLETED